Why US Ebola funding is hidden inside Pentagon war bills — RT Africa

When news emerged that Kenya had authorized a 50-bed, American-funded Ebola isolation centre at Laikipia Air Base in Nanyuki, the controversy immediately eclipsed medical logistics. The premise was stark: Quarantine US citizens exposed to the virus offshore to prevent them from entering US territory.

The backlash was fiercely swift. Opposition politicians, civil society groups, and citizens secured court injunctions and poured into the streets. The situation turned deadly when police cracked down on demonstrators in Nanyuki, leaving at least three people dead. What Washington framed as a pragmatic health measure has instead ignited a volatile debate over national sovereignty, neo-colonial health policies, and the cost of Western risk externalization.

On May 29, Kenya’s High Court halted the project. Responding to a petition led by the Katiba Institute and medical unions, Justice Patricia Nyaundi issued sweeping orders halting the US facility at Laikipia. The mandate went beyond stopping construction; it barred Kenyan authorities from facilitating the entry of Ebola-exposed individuals and compelled Nairobi to disclose all bilateral agreements with Washington.

This raised a fundamental question: Why should African nations absorb the risks of managing global pathogens with minimal control over the response? The dispute highlights growing tensions in global health cooperation. While Western partnerships are often framed as mutually beneficial, critics argue they are profoundly imbalanced. Funding and technology may flow from wealthier nations, but the operational risk, implementation burden, and political fallout are borne almost entirely by host countries.

For the petitioners, the state had engaged in “constitutional recklessness.” They successfully argued that hosting a Level-4 biohazard risk was negotiated in secrecy, completely bypassing parliamentary oversight and mandatory public participation. By agreeing to function as an alternative containment site, Nairobi allowed a foreign power to externalize its disease risk management, exposing a local population – in a country with zero confirmed Ebola cases – to an unacceptable imported threat.

The legal battle reached a dramatic point last week, underscoring the lengths to which the government initially went to accommodate Washington. Despite the clear judicial freeze issued in late May, work at the site quietly continued.

On June 22, the High Court held Health Cabinet Secretary Aden Duale in contempt for actively ignoring the injunction. Facing the unprecedented prospect of severe judicial sanctions, the minister was forced into a humiliating capitulation. Appearing personally before Justice Nyaundi the next day, Duale tendered a formal apology, expressing “sincere regret” for undermining the judiciary. More importantly, he confirmed to the court that he had finally ordered the “immediate and complete cessation of any intended construction, site preparation, or related activities” at the Laikipia facility.

While Duale was discharged with a strict warning, his forced public retreat represented a monumental victory for Kenyan civil society and a sharp rebuke to executive overreach driven by foreign health agendas.

To understand the depth of the Kenyan backlash, one must look beyond Kenya itself and examine how Washington intends to bankroll it. On June 25, the White House requested $1.4 billion for the African Ebola response – a figure that reportedly includes hundreds of millions explicitly earmarked for the very Kenyan quarantine center the High Court just halted. This is not standalone humanitarian aid; the request is buried inside a massive $87.6 billion emergency supplemental package designed almost entirely to replenish the Pentagon for military operations.

Bundling pathogen containment into an offensive, unpopular, war-funding bill exposes a rapidly developing across the continent: The US approach to global health in Africa has shifted from ostensibly unconditional aid to a defensive, militarized security perimeter. Under this transactional ‘America First’ framework, Washington utilizes Bilateral Global Health Agreements (BGHAs) to squeeze partner governments, demanding real-time access to sovereign digital health systems, patient data, and valuable pathogen specimens in exchange for funding – externalizing the operational and biological risks of managing global outbreaks directly onto African soil.

The friction in Nairobi is mirrored perfectly by recent diplomatic ruptures in Harare and Accra. In February 2026, Zimbabwe abruptly halted negotiations with Washington over a proposed $367 million health funding package. The talks unravelled because of US demand for long-term access to Zimbabwe’s sensitive epidemiological data and biological pathogen samples.

Zimbabwean officials rejected the terms as a breach of national security and data sovereignty, pointing out the inherent neo-colonial asymmetry: The agreement would force the nation to provide the raw materials for scientific discovery without any reciprocal guarantee of access to the resulting vaccines or treatments.

In April, Ghana similarly withdrew from health negotiations, citing the exact same concerns over overreaching US demands for data access.

Meanwhile, in Uganda, the US successfully leveraged funding to secure direct, real-time access to nine of the nation’s central health data systems for seven years, raising massive alarms among digital privacy and human rights experts regarding the unchecked extraction of African medical records by foreign entities.

When placed alongside these continent-wide manoeuvres, the Kenyan quarantine dispute is no longer an isolated incident of local public outrage. It is the physical manifestation of what critics increasingly describe as ‘parachute science’ – an extractive architecture of global health governance where African nations are coerced into surrendering their data, biological resources, and even their physical territory to manage Western risks, while the intellectual property, strategic benefits, and biomedical innovations remain securely locked within US borders.

This transactional and coercive approach to health is now being aggressively deployed to punish geopolitical defiance. The most glaring example is currently unfolding in South Africa. In June 2026, the US State Department confirmed a phased termination of funding under the President’s Emergency Plan for AIDS Relief (PEPFAR) – a program that historically provided hundreds of millions annually to combat the world’s largest HIV epidemic. The official pretext for dismantling this critical infrastructure relies on highly controversial, politically motivated allegations regarding South Africa’s land policies and domestic economic transformation frameworks.

However, this manufactured narrative was brought to a head during South African President Cyril Ramaphosa’s highly publicized Oval Office visit in May 2025. When confronted by the US administration with sensationalized claims regarding the safety of the country’s minority population, Ramaphosa did not simply offer a standard diplomatic rebuttal.

He arrived with a delegation that included prominent figures such as his then-minister of agriculture, John Steenhuisen, and billionaire Johann Rupert. Standing firmly before the international press, the delegation directly addressed the assertions, clarifying that while South Africa battles severe national crime and violence, it is indiscriminate, overwhelmingly affects black South Africans, and is entirely devoid of state-sponsored racial targeting.

The diplomatic timeline further reveals this health funding cut to be a calculated smokescreen. This devastating withdrawal of aid is part of a broader, sustained campaign of economic and political retaliation that included the imposition of crippling 30% tariffs on South African industrial and manufactured exports in 2025.

The true catalyst for Washington’s punitive measures is not a sudden concern for minority rights, but rather Pretoria’s non-aligned foreign policy – specifically, its historic sovereign decision to bring a genocide case, supported by numerous other states, against Israel before the International Court of Justice (ICJ). By weaponizing HIV/AIDS funding to settle geopolitical scores, the US has unequivocally demonstrated that African public health is viewed not as a humanitarian imperative, but as a strategic lever to be pulled whenever a sovereign nation refuses to comply.

This transformation of healthcare diplomacy into coercive policy tactics reveals that the US is ready to walk away from its global commitments to the world. By discarding multilateral health governance in favor of transactional bilateralism – accelerated by Washington’s formal exit from the World Health Organization in January 2026 – the US State Department is establishing a neo-colonial division of labor in global biosecurity.

In this new paradigm, the Global South is designated to absorb the physical containment risks and biological fallout of emerging pathogens, while the West retains an absolute monopoly on the resulting scientific breakthroughs, intellectual property, healthcare costs and medical countermeasures. It reduces sovereign states to biological data-farms and offshore quarantine zones.

The resistance unfolding from Nairobi to Harare is a necessary pushback against an unequal international order where national dignity, data sovereignty, and equal treatment are continually sacrificed to shield Western populations from the very risks they externalize.